Alpha 2.0
Login Register
» Articles » PMID: 27246604

HIV Infection is Associated with Higher Levels of Monocyte Chemoattractant Protein-1 and Eotaxin Among People with Recent Hepatitis C Virus Infection

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Specialty Infectious Diseases
Date 2016 Jun 2
PMID 27246604
Citations 6
Authors
Francois M J Lamoury
Behzad Hajarizadeh
Elizabeth Keoshkerian
Jordan J Feld
Janaki Amin
Suzy Teutsch
Gail V Matthews
Margaret Hellard
Gregory J Dore
Andrew R Lloyd
Tanya L Applegate
Jason Grebely
Affiliations
Soon will be listed here.
Abstract

Background: Human immunodeficiency virus (HIV) infection leads to more rapid progression of hepatitis C virus (HCV)-related liver fibrosis, which could be linked to differences in the severity of liver inflammation among HIV/HCV co-infected individuals compared to HCV mono-infected individuals. This study assessed the association of HIV co-infection with pro-inflammatory and pro-fibrogenic cytokines and chemokines during recent HCV infection.

Methods: Participants from the ATAHC study, a prospective cohort of recent HCV infection, with detectable HCV RNA at the time of acute HCV detection were included. Concentrations of 27 plasma cytokines and chemokines were measured by multiplex immunoassays and compared between those with, and without, HIV co-infection.

Results: Out of 117 individuals with recent HCV infection included in analysis, 73 had HCV mono-infection and 44 had HIV/HCV co-infection. Individuals with HIV/HCV co-infection had significantly higher mean levels of eotaxin (1.79 vs. 1.62 log pg/mL; P < 0.001), monocyte chemotactic protein 1 (MCP-1; 2.10 vs. 1.98 log pg/mL; P < 0.001), and interferon-gamma inducible protein-10 (IP-10; 3.11 vs. 2.98 log pg/mL; P = 0.013). Linear regression analyses adjusting for age, alanine transaminase (ALT), HCV RNA levels, and assay run, higher eotaxin levels were independently associated with HIV/HCV co-infection (adjusted β: 0.12; 95%CI: 0.01, 0.24; P = 0.039). Higher MCP-1 levels were also independently associated with HIV/HCV co-infection in adjusted analysis (adjusted β: 0.11; 95%CI: 0.03, 0.18; P = 0.009).

Conclusions: During recent HCV, those with HIV/HCV co-infection had a stronger pro-fibrogenic mediator profile compared to those with HCV mono-infection. These findings may provide a potential explanation for accelerated liver fibrosis in HIV/HCV co-infection.

Trial Registration: Australian Trial in Acute Hepatitis C (ATAHC) study was registered with ClinicalTrials.gov registry on September 11, 2005. NCT00192569 .

Citing Articles

Cytokine profiles as predictors of HIV incidence using machine learning survival models and statistical interpretable techniques.

Ogutu S, Mohammed M, Mwambi H Sci Rep. 2024; 14(1):29895.

PMID: 39622992 PMC: 11612445. DOI: 10.1038/s41598-024-81510-y.

Infection with HIV-1 subtype D among acutely infected Ugandans is associated with higher median concentration of cytokines compared to subtype A.

Kapaata A, Balinda S, Hare J, Leonova O, Kikaire B, Egesa M IJID Reg. 2022; 3:89-95.

PMID: 35755471 PMC: 9205166. DOI: 10.1016/j.ijregi.2022.03.007.

Simian Immunodeficiency Virus Infection Mediated Changes in Jejunum and Peripheral SARS-CoV-2 Receptor ACE2 and Associated Proteins or Genes in Rhesus Macaques.

Boby N, Cao X, Williams K, Gadila S, Shroyer M, Didier P Front Immunol. 2022; 13:835686.

PMID: 35281029 PMC: 8914048. DOI: 10.3389/fimmu.2022.835686.

Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial.

Tan D, Rolon M, Figueroa M, Sued O, Gun A, Kaul R PLoS One. 2019; 14(9):e0221653.

PMID: 31490959 PMC: 6730918. DOI: 10.1371/journal.pone.0221653.

High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid.

Booiman T, Wit F, Maurer I, De Francesco D, Sabin C, Harskamp A Open Forum Infect Dis. 2017; 4(3):ofx108.

PMID: 28680905 PMC: 5494939. DOI: 10.1093/ofid/ofx108.

References
1.
Mitchell C, Couton D, Couty J, Anson M, Crain A, Bizet V . Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice. Am J Pathol. 2009; 174(5):1766-75. PMC: 2671265. DOI: 10.2353/ajpath.2009.080632. View
2.
Heijmans-Antonissen C, Wesseldijk F, Munnikes R, Huygen F, van der Meijden P, Hop W . Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1. Mediators Inflamm. 2006; 2006(1):28398. PMC: 1570387. DOI: 10.1155/MI/2006/28398. View
3.
Tuyama A, Hong F, Saiman Y, Wang C, Ozkok D, Mosoian A . Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis. Hepatology. 2010; 52(2):612-22. PMC: 2917256. DOI: 10.1002/hep.23679. View
4.
Tacke F, Trautwein C, Yagmur E, Hellerbrand C, Wiest R, Brenner D . Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course. J Gastroenterol Hepatol. 2007; 22(8):1256-64. DOI: 10.1111/j.1440-1746.2006.04621.x. View
5.
Stacey A, Norris P, Qin L, Haygreen E, Taylor E, Heitman J . Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol. 2009; 83(8):3719-33. PMC: 2663284. DOI: 10.1128/JVI.01844-08. View